Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Omrix initiates Phase II trial for Fibrin Patch
The Phase II clinical trial is a randomized, controlled clinical study in soft tissue to evaluate the superiority of the Fibrin Patch compared to Surgicel. The primary endpoint
The Phase II clinical trial is a randomized, controlled clinical study in soft tissue to evaluate the superiority of the Fibrin Patch compared to Surgicel. The primary endpoint
It is anticipated that Pradaxa will be launched in Germany and the UK in the coming weeks. Pradaxa is approved for the prevention of venous thromboembolic events in
Preliminary evaluation of biological samples collected from the study’s first and second cohorts indicated that administration of HspE7 results in an E7-specific T-cell immune response. Nventa believes that
The intention with the new Phase IIb dose ranging study is to expand the clinical and commercial potential for eprotirome in dyslipidemia treatment by exploring whether eprotirome in
The agreement sets the terms under which Novation members can acquire Olympus AU series analyzers, automation systems, reagents, consumables, parts, service and technical support. The contract spans three
Under the agreement, Ono will pay to Evotec initial payments (technology access fee) for access to Evotec’s fragment-based drug discovery platform, EVOlution, research funding as well as success-based
Quintiles will have its own staff at the College of American Pathologists-certified Medca Japan laboratory in Saitama, a city in the Greater Tokyo area. The lab will support
The company expects to begin commercial sales of the Endeavor stent in Canada by the end of March, 2008. Medtronic will also provide annual updates on its Endeavor
Alliant’s cardiovascular products are primarily used during open heart surgeries. One of the newly contracted products, vein graft cannulas, allows the surgeon to inspect blood vessels prior to
The problem concerns a supplied component in the device used to deliver the fentanyl spray which may result in patients receiving a sub-optimal dose of medication. A detailed